CEO Roger Susi was paid $780,598 in fiscal year 2025, ↑ up 13.2% from fiscal year 2024 (SEC filing 0001628280-26-028903 ↗): executive and director compensation, incentive-plan design, equity activity, and governance — every figure in this brief is traceable to its exact location in the company’s SEC filing — the document, the section, the page, and the table, linked directly.
$780,598 ↑ Roger Susi total, FY2025 | — CEO pay percentile vs peers | — CEO-to-median pay ratio | 99% Say-on-pay support, latest vote |
Track this company's pay every filing: join the Pro seat waitlist
Velarion Pro: every company page, peer tools and exports, one seat — $1,200/year
Ask our research desk — $99, 24h, every figure cited to its filing.
IRMD's next annual pay disclosure, estimated April 30, 2027.est. Filing ↗
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Roger Susi | $385,598 | $0 | $0 | $0 | $395,000 | $0 | $0 | $780,598 |
| President and Chief Executive Officer | ||||||||
| John Glenn | 378,933 | 0 | 0 | 0 | 200,000 | 0 | 31,061 | 609,994 |
| Chief Financial Officer | ||||||||
| Jeffrey Chiprin | 205,000 | 0 | 0 | 0 | 228,000 | 0 | 96,360 | 529,360 |
| Chief Commercial Officer | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
| Named executive officer | FY2025 total | FY2024 total | FY2023 total | Δ FY2024→2025 |
|---|---|---|---|---|
| Roger Susi | $780,598 | $689,580 | $642,566 | ↑ +91,018 |
| John Glenn | 609,994 | 1,262,892 | 1,267,324 | ↓ −652,898 |
| Jeffrey Chiprin | 529,360 | 388,683 | — | ↑ +140,677 |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
You have just read Iradimed's Summary Compensation Table. The whole free brief as a PDF, emailed now, with every figure cited — then a few short notes on the deeper IRMD reports.
We send the PDF right away, then up to three short notes. Reply “unsubscribe” to any of them, any time.
How we handle your data → Privacy
Each company listed discloses IRMD in its own benchmarking peer group, as disclosed in each company's most recent proxy statement within the last two proxy seasons. Two companies are therefore absent by design: one that named IRMD in an earlier year and no longer does, and one whose own most recent disclosure is older than the last two seasons.
One page per director: the seat, the committees and the fee table, read for one person at a time.
| Director | Role | FY2025 total |
|---|---|---|
| Anthony Vuoto | Former director (through FY2025) | $61,195 |
| Hilda Scharen-Guivel | Independent Director | $162,412 |
| James Hawkins | Director | $149,912 |
| Joe Kiani | Independent Director | $172,006 |
| Monty Allen | Independent Director | $169,912 |
No insider equity transactions reported since the proxy statement.
| Executive | Award | Grant date | Threshold | Target | Granted | Maximum | Grant-date fair value |
|---|---|---|---|---|---|---|---|
| John Glenn | RSU | 2022-05-21 | — | — | — | — | $750,000 |
| Named executive officer | Time-vested (RSU) | Performance-vested (PSU) | Options / SARs | % performance-vested |
|---|---|---|---|---|
| John Glenn | $750,000 | $0 | $0 | 0.0% |
% performance-vested = PSU grant-date fair value ÷ (RSU + PSU + Options), a computed value with the derivation shown in the register.
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| John Glenn | PSU | 14,360 | — | $1,396,941 |
| John Glenn | PSU | 10,872 | — | 1,057,628 |
| John Glenn | RSU | 7,180 | — | 698,470 |
| Jeffrey Chiprin | PSU | 5,978 | — | 581,540 |
| John Glenn | RSU | 5,796 | — | 563,835 |
| John Glenn | RSU | 3,624 | — | 352,543 |
| Jeffrey Chiprin | RSU | 1,994 | — | 193,976 |
Our compensation philosophy is to offer our named executive officers compensation and benefits that are competitive and meet our goals of attracting, retaining, and motivating highly skilled management, which is necessary to achieve our financial and strategic objectives and create long-term value for our stockholders.
| CEO STI target (% of salary) | — |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | — |
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2026 | 2026-06-23 | 10,487,387 | 106,030 | 17,519 | 99% | Passed |
| 2025 | 2025-06-19 | 10,777,171 | 286,889 | 13,963 | 97.41% | Passed |
| 2024 | 2024-06-20 | 10,684,897 | 197,682 | 32,812 | 98.18% | Passed |
| 2023 | 2023-06-15 | 10,782,715 | 133,595 | 4,591 | 98.78% | Passed |
| 2022 | 2022-06-10 | 10,235,323 | 139,607 | 18,142 | 98.65% | Passed |
| 2021 | 2021-06-11 | 10,215,141 | 63,093 | 31,343 | 99.39% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year's compensation.
| Meeting year | Meeting date | Approval — company's computation |
|---|---|---|
| 2026 | 2026-06-23 | 99%a |
| 2025 | 2025-06-19 | 97.41%b |
| 2024 | 2024-06-20 | 98.18%c |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
c. Approved under the standard stated in the filing — “not treated as a vote cast, except for quorum purposes Yes As this proposal is considered routine under The Nasdaq Stock Market ("NASDAQ") rules, there will be no broker non-votes on this proposal Say-on-Pay FOR AGAINST ABSTAIN More FOR votes than AGAINST votes Abstention votes have no effect;”.
Approval percentages are the company's own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| Joe KianiIndependent · Audit · Compensation · Newly elected | $22,067 | $149,939 | — | — | — | $172,006 |
| Monty AllenIndependent · Audit (Chair) · Compensation | 70,000 | 99,912 | — | — | — | 169,912 |
| Hilda Scharen-GuivelIndependent · Audit · Compensation | 62,500 | 99,912 | — | — | — | 162,412 |
| James HawkinsNot independent | 50,000 | 99,912 | — | — | — | 149,912 |
| Anthony VuotoIndependent · Audit · Compensation · Departed during FY | 61,195 | 0 | — | — | — | 61,195 |
| Roger SusiEmployee director · Board Chair | — | — | — | — | — | 0 |
| Annual cash retainer | $50,000 |
|---|---|
| Annual equity retainer | $100,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 15,000 / 10,000 |
| Stock ownership guideline | — |
| Component | FY2025 |
|---|---|
| Cash retainers and fees | $265,762 |
| Equity awards (grant-date value) | $449,675 |
| All other compensation | $0 |
| Total cost of the board | $715,437 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company's own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Iradimed | 2025 | Roger Susi | $385,598 | $0 | $0 | $395,000 | $780,598 |
Each peer's compensation is from its most recently filed proxy; fiscal years differ by company. Each peer's figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Each figure's location is given both for the eye (section · page · table · row · column) and for a script (table/row/column index and exact character span in the filed document). Any figure can be independently confirmed against the source.
| # | Supports | Document | Filed | Accession | Location in document |
|---|---|---|---|---|---|
| 1 | Section 01, Roger Susi | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Executive Compensation”. As printed: 780,598. Filing ↗machine: r3 · c36 · span 177624–177631 |
| 2 | Section 01, John Glenn | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Executive Compensation”. As printed: 609,994. Filing ↗machine: r10 · c36 · span 190511–190518 |
| 3 | Section 01, Jeffrey Chiprin | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Executive Compensation”. As printed: 529,360. Filing ↗machine: r7 · c36 · span 184223–184230 |
| 4 | Section 03, John Glenn RSU | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Executive Compensation” · grants of plan-based awards table. Filing ↗machine: span 200543–200551 |
| 5 | Section 08, Joe Kiani | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Director Compensation”. As printed: 172,006. Filing ↗machine: span 307801–307933 |
| 6 | Section 08, Monty Allen | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Director Compensation”. As printed: 169,912. Filing ↗machine: span 304048–304180 |
| 7 | Section 08, Hilda Scharen-Guivel | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Director Compensation”. As printed: 162,412. Filing ↗machine: span 309542–309674 |
| 8 | Section 08, James Hawkins | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Director Compensation”. As printed: 149,912. Filing ↗machine: span 305814–305946 |
| 9 | Section 08, Anthony Vuoto | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Director Compensation”. As printed: 61,195. Filing ↗machine: span 310091–310332 |
| 10 | Section 08, Roger Susi | DEF 14A | 2026-04-30 | 0001628280-26-028903 | Section “Director Compensation”. As printed: 0. Filing ↗ |
| 11 | Section 06, 2026 vote | Form 8-K | 2026-06-24 | 0001628280-26-045059 | Item 5.07 · say-on-pay result. As reported: 99% (votes for as printed: 10,487,387). Filing ↗ |
| 12 | Section 06, 2025 vote | Form 8-K | 2025-06-23 | 0001558370-25-008791 | Item 5.07 · say-on-pay result. As reported: 97.41% (votes for as printed: 10,777,171). Filing ↗ |
| 13 | Section 06, 2024 vote | Form 8-K | 2024-06-20 | 0001558370-24-009354 | Item 5.07 · say-on-pay result. As reported: 98.18% (votes for as printed: 10,684,897). Filing ↗ |
| 14 | Section 01 trend, Δ column (computed) | Computed | — | — | Δ = current-FY total − prior-FY total per named officer.machine: formula: Δ = FY(n) − FY(n−1) |
| 15 | Section 03b vehicle mix (computed) | Computed | — | — | RSU / PSU / Options grant-date fair values summed per officer from the grants table; % performance-vested = PSU ÷ (RSU+PSU+Options).machine: formula: sums + PSU ratio |
| 16 | Section 09b board cost (computed) | Computed | — | — | Cash 265,762 + equity 449,675 + all other 0 = 715,437, summed across the director compensation table rows.machine: formula: Σ = 715,437 |
| 17 | Iradimed (subject), Section 10b CEO total | DEF 14A | 2026-04-30 | 0001628280-26-028903 | CEO total compensation as printed in Iradimed's own proxy. As printed: 780,598. Filing ↗machine: r3 · c36 · span 177624–177631 |
The Pay Desk — the free weekly executive pay briefing, one company at a time, every number traceable to a public filing.
You'll confirm on The Pay Desk's sign-up page.